- Home
- ANEB vs ORIS Comparison
ANEB vs ORIS Comparison
Compare ANEB & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- ORIS
- Stock Information
- Founded
- ANEB 2020
- ORIS 2014
- Country
- ANEB United States
- ORIS China
- Employees
- ANEB N/A
- ORIS N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- ORIS Farming/Seeds/Milling
- Sector
- ANEB Health Care
- ORIS Consumer Staples
- Exchange
- ANEB Nasdaq
- ORIS Nasdaq
- Market Cap
- ANEB 39.0M
- ORIS 12.1M
- IPO Year
- ANEB 2021
- ORIS 2024
- Fundamental
- Price
- ANEB $1.66
- ORIS $0.65
- Analyst Decision
- ANEB Strong Buy
- ORIS
- Analyst Count
- ANEB 2
- ORIS 0
- Target Price
- ANEB $5.50
- ORIS N/A
- AVG Volume (30 Days)
- ANEB 21.1K
- ORIS 190.5K
- Earning Date
- ANEB 05-13-2025
- ORIS 02-21-2025
- Dividend Yield
- ANEB N/A
- ORIS N/A
- EPS Growth
- ANEB N/A
- ORIS N/A
- EPS
- ANEB N/A
- ORIS 0.17
- Revenue
- ANEB N/A
- ORIS $15,014,000.00
- Revenue This Year
- ANEB N/A
- ORIS N/A
- Revenue Next Year
- ANEB N/A
- ORIS N/A
- P/E Ratio
- ANEB N/A
- ORIS $3.60
- Revenue Growth
- ANEB N/A
- ORIS N/A
- 52 Week Low
- ANEB $0.80
- ORIS $0.50
- 52 Week High
- ANEB $3.08
- ORIS $56.01
- Technical
- Relative Strength Index (RSI)
- ANEB 59.78
- ORIS N/A
- Support Level
- ANEB $1.57
- ORIS N/A
- Resistance Level
- ANEB $2.00
- ORIS N/A
- Average True Range (ATR)
- ANEB 0.25
- ORIS 0.00
- MACD
- ANEB 0.00
- ORIS 0.00
- Stochastic Oscillator
- ANEB 30.25
- ORIS 0.00
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).